1-7 of 7
P Morel
Close
Sort by
Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) in Waldenström Macroglobulinemia (Wm), Update of the French Experience in 54 Cases.

N. Dhedin, MD, R. Tabrizi, MD, P.E. Bulabois, MD, S. Le Gouill, MD, V. Coiteux, MD, C. Dartigeas, MD, M. Robin, MD, A. Huynh, MD, F. Larosa, MD, V. Cacheux, MD, A. Garnier, MD, P. Morel, MD, M. Kuentz, MD, B. Dreyfus, MD, B. Desablens, MD, G. Guillerm, MD, B. Pignon, MD, B. Rio, MD, K. Bilger, MD, A. Cabrespine, MD, M. Uzunov, MD, Jacques-Olivier Bay, MD, PHD, V. Leblond, MD, O. Tournihac, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3015.
https://doi.org/10.1182/blood.V110.11.3015.3015
Published: 2007
Journal Articles

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

F. Morschhauser, D. Huglo, G. Martinelli, G. Paganelli, P.L. Zinzani, D. Hadjiyiannakis, A. Liberati, T. Illidge, N. Milpied, H. Stein, J. Kalmus, P. Morel, U. Reimann, R. Marcus
Journal: Blood
Blood (2004) 104 (11): 130.
https://doi.org/10.1182/blood.V104.11.130.130
Published: 2004
Journal Articles

Bone Marrow Versus Peripheral Blood Progenitor Cells CD34 Selection in Patients With Non-Hodgkin's Lymphomas: Different Levels of Tumor Cell Reduction. Implications for Autografting

M. Lopez, F.M. Lemoine, H. Firat, L. Fouillard, J.P. Laporte, S. Lesage, F. Isnard, J. Stachowiak, F. Ferrer-Le Coeur, P. Morel, A. Najman, L. Douay, N.C. Gorin
Journal: Blood
Blood (1997) 90 (7): 2830–2838.
https://doi.org/10.1182/blood.V90.7.2830
Published: 1997
Journal Articles

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]

B Dupriez, P Morel, JL Demory, JL Lai, M Simon, I Plantier, F Bauters
Journal: Blood
Blood (1996) 88 (3): 1013–1018.
https://doi.org/10.1182/blood.V88.3.1013.1013
Published: 1996
Journal Articles

Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis

JL Lai, M Zandecki, JY Mary, F Bernardi, V Izydorczyk, M Flactif, P Morel, JP Jouet, F Bauters, T Facon
Journal: Blood
Blood (1995) 85 (9): 2490–2497.
https://doi.org/10.1182/blood.V85.9.2490.bloodjournal8592490
Published: 1995
Journal Articles

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

E Wattel, C Preudhomme, B Hecquet, M Vanrumbeke, B Quesnel, I Dervite, P Morel, P Fenaux
Journal: Blood
Blood (1994) 84 (9): 3148–3157.
https://doi.org/10.1182/blood.V84.9.3148.3148
Published: 1994
Journal Articles

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, T Lamy, H Tilly, A Guerci, F Maloisel
Journal: Blood
Blood (1992) 80 (9): 2176–2181.
https://doi.org/10.1182/blood.V80.9.2176.2176
Published: 1992